What is Replimune Group's long-term debt?

Replimune Group (REPL) reported long-term debt of $47.63M in Q4 2025.

How has Replimune Group's long-term debt changed year-over-year?

Replimune Group's long-term debt increased by 3.6% year-over-year, from $45.96M to $47.63M.

What does long-term debt mean?

Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.

Replimune Group REPL Long-Term Debt

Long-Term Debt at other companies

AmgenAMGN

$51.89B-3.9%

Regeneron PharmaceuticalsREGN

$1.99B+0.1%

Inhibrx Biosciences, Inc.INBX

$174.99M+77.4%

CG OncologyCGON

$3M—

Arcus BiosciencesRCUS

$100M+108%

ImmunityBio, Inc.IBRX

$404.3M+36.5%

Other financials

Income statement

See full

Operating income-$71.9M-8.9%

Net income-$70.9M-6.9%

EPS (diluted)-$0.77+2.5%

Balance sheet

See full

Cash & equivalents$124.7M-28.3%

Total debt$79.2M+0.5%

Total equity$210.5M-56.4%

Total assets$333.6M-44.7%

Cash flow

See full

Operating cash flow-$66.0M-30.1%

CapEx$135.0K-92.5%

Free cash flow-$66.1M-25.9%

Valuation

See full

Market cap$930.59M+30.2%

Enterprise value$885.15M+30.0%

Returns & leverage

See full

Return on equity-90.9%+362pp

Debt / equity0.4×+0.2×

Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.

The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Replimune Group's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Replimune Group's long-term debt?: Replimune Group (REPL) reported long-term debt of $47.63M in Q4 2025.
How has Replimune Group's long-term debt changed year-over-year?: Replimune Group's long-term debt increased by 3.6% year-over-year, from $45.96M to $47.63M.
What does long-term debt mean?: Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.